Mugale MN - Search Results

1

Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.

Verma S, Dal NK, Srivastava A, Bharti R, Siva Reddy DV, Sofi HS, Roy T, Verma K, Raman SK, Azmi L, Ray L, Mugale MN, Singh AK, Singh J, Griffiths G, Misra A. Verma S, et al. Among authors: mugale mn. AAPS PharmSciTech. 2023 Jun 8;24(5):130. doi: 10.1208/s12249-023-02585-w. AAPS PharmSciTech. 2023. PMID: 37291443

2

Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis.

Bharti R, Roy T, Verma S, Reddy DVS, Shafi H, Verma K, Raman SK, Pal S, Azmi L, Singh AK, Ray L, Mugale MN, Misra A. Bharti R, et al. Among authors: mugale mn. Tuberculosis (Edinb). 2022 May;134:102198. doi: 10.1016/j.tube.2022.102198. Epub 2022 Mar 18. Tuberculosis (Edinb). 2022. PMID: 35344918

3

Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis.

Reddy DVS, Shafi H, Bharti R, Roy T, Verma S, Raman SK, Verma K, Azmi L, Ray L, Singh J, Singh AK, Mugale MN, Misra A. Reddy DVS, et al. Among authors: mugale mn. Pharm Res. 2022 Oct;39(10):2621-2633. doi: 10.1007/s11095-022-03360-5. Epub 2022 Aug 12. Pharm Res. 2022. PMID: 35962268 Free PMC article.

4

Correction: Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis.

Reddy DVS, Shaf H, Bharti R, Roy T, Verma S, Raman SK, Verma K, Azmi L, Ray L, Singh J, Singh AK, Mugale MN, Misra A. Reddy DVS, et al. Among authors: mugale mn. Pharm Res. 2022 Nov;39(11):3039. doi: 10.1007/s11095-022-03418-4. Pharm Res. 2022. PMID: 36266375 Free PMC article. No abstract available.

5

Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens.

Imran M, Singh S, Ahmad MN, Malik P, Mukhopadhyay A, Yadav KS, Gupta UD, Mugale MN, Mitra K, Srivastava KK, Chopra S, Mignani S, Apartsin E, Majoral JP, Dasgupta A. Imran M, et al. Among authors: mugale mn. Biomed Pharmacother. 2024 Apr;173:116289. doi: 10.1016/j.biopha.2024.116289. Epub 2024 Mar 6. Biomed Pharmacother. 2024. PMID: 38452653 Free article.

6

Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy.

Singh N, Marwaha D, Gautam S, Rai N, Tiwari P, Sharma M, Shukla RP, Mugale MN, Kumar A, Mishra PR. Singh N, et al. Among authors: mugale mn. Biomacromolecules. 2023 Dec 11;24(12):5780-5796. doi: 10.1021/acs.biomac.3c00795. Epub 2023 Nov 25. Biomacromolecules. 2023. PMID: 38006339

7

Safety assessment of the pharmacological excipient, diethylene glycol monoethyl ether (DEGEE), using in vitro and in vivo systems.

Srivastava S, Mishra S, Dewangan J, Divakar A, Gupta N, Kalleti N, Mugale MN, Kumar S, Sharma S, Rath SK. Srivastava S, et al. Among authors: mugale mn. Daru. 2019 Jun;27(1):219-231. doi: 10.1007/s40199-019-00264-5. Epub 2019 Apr 18. Daru. 2019. PMID: 31001735 Free PMC article.

8

Liquiritigenin, isoliquiritigenin rich extract of glycyrrhiza glabra roots attenuates inflammation in macrophages and collagen-induced arthritis in rats.

Babu V, Kapkoti DS, Binwal M, Bhakuni RS, Shanker K, Singh M, Tandon S, Mugale MN, Kumar N, Bawankule DU. Babu V, et al. Among authors: mugale mn. Inflammopharmacology. 2023 Apr;31(2):983-996. doi: 10.1007/s10787-023-01152-w. Epub 2023 Mar 22. Inflammopharmacology. 2023. PMID: 36947299

9

Synergistic delivery of Imatinib through multifunctional nano-crystalline capsules, in response to redox environment for improved breast cancer therapy.

Marwaha D, Gautam S, Singh N, Rai N, Sharma M, Tiwari P, Shukla RP, Urandur S, Banala VT, Mugale MN, Kumar A, Mishra PR. Marwaha D, et al. Among authors: mugale mn. Colloids Surf B Biointerfaces. 2023 Jun;226:113316. doi: 10.1016/j.colsurfb.2023.113316. Epub 2023 Apr 13. Colloids Surf B Biointerfaces. 2023. PMID: 37086687

10

Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis.

Sanap SN, Bisen AC, Kedar A, Yadav KS, Krishna A, Akhir A, Chopra S, Mugale MN, Bhatta RS. Sanap SN, et al. Among authors: mugale mn. Int J Biol Macromol. 2022 Dec 1;222(Pt B):2785-2795. doi: 10.1016/j.ijbiomac.2022.10.058. Epub 2022 Oct 11. Int J Biol Macromol. 2022. PMID: 36240895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page